They found that serum endocan levels were significantly higher among HD patients in comparison with CKD without HD patients (146 [46 – 337] pg/ml vs. 86 [26 – 207] pg/ml, p-value < 0.001). The gene discussed is ESM1; the disease is Huntington disease.